Share Price and Basic Stock Data
Last Updated: November 15, 2025, 10:10 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Alchemist Corporation Ltd operates in the chemicals sector, specifically focusing on inorganic chemicals. The company has faced significant challenges in generating sales, with reported revenues consistently at ₹0.00 for the quarters ending from June 2022 through March 2025. This persistent lack of revenue generation raises concerns about the company’s operational viability and market positioning. Over the years, Alchemist’s sales figures have shown a declining trend, with the last significant revenue recorded being ₹0.46 Cr in March 2021. The company’s inability to return to a revenue-generating state may reflect broader issues within its business strategy or market conditions. In contrast, the overall chemicals industry in India has been growing, with a compound annual growth rate (CAGR) of approximately 7.5% from 2021 to 2026, according to the Indian Chemical Council. Alchemist’s stagnation in sales thus stands in stark contrast to the sector’s growth trajectory.
Profitability and Efficiency Metrics
Alchemist Corporation has exhibited troubling profitability metrics, with a net profit of ₹-0.31 Cr as of the latest data. The company’s operating profit margins have remained negative, with the most recent quarterly report showing an operating profit of ₹-0.12 Cr for March 2024. The operating profit margin (OPM) has been consistently negative, indicating that the company is struggling to cover its operational costs. The return on equity (ROE) stood at 9.02%, which is relatively low for the industry. Furthermore, the interest coverage ratio (ICR) was recorded at -3.08x, suggesting that Alchemist is not generating sufficient earnings to meet its interest obligations. This alarming financial distress is compounded by a history of negative net profits, with marked losses in the past years, raising significant red flags for potential investors.
Balance Sheet Strength and Financial Ratios
Alchemist’s balance sheet shows significant weaknesses, primarily illustrated by the absence of reported reserves and borrowings. The company’s total debt to equity ratio stood at 1.28, indicating that the firm is highly leveraged. While the current ratio is a more favorable 1.72, suggesting the company can cover its short-term liabilities, the overall financial health remains precarious. The book value per share has declined to ₹1.13 as of March 2025, compared to ₹4.75 in March 2021, highlighting a substantial erosion of shareholder value. Additionally, the price-to-book value (P/BV) ratio at 10.18x is considerably high compared to typical sector ranges, indicating that investors may be paying a premium for the stock despite its weak fundamentals. The company’s financial ratios suggest a lack of operational efficiency and capital management, which could deter potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Alchemist Corporation indicates a strong promoter holding of 74.11%, which has remained stable since December 2022. This high level of promoter ownership often reflects confidence in the company’s long-term prospects; however, it may also signal a lack of external investor interest, as foreign institutional investors (FIIs) and domestic institutional investors (DIIs) are not reported. The public shareholding is recorded at 25.88%, with the number of shareholders increasing from 1,555 in December 2022 to 1,601 by March 2025, which suggests some level of interest from retail investors despite the company’s financial struggles. However, the lack of institutional backing could be a concern for future capital raising and may affect the stock’s liquidity in the market. Overall, while the promoter’s consistent stake suggests commitment, the absence of broader investor confidence poses risks for the company’s future.
Outlook, Risks, and Final Insight
The outlook for Alchemist Corporation remains uncertain, primarily due to its ongoing challenges in generating revenue and maintaining profitability. The absence of sales coupled with negative operating profit margins indicates an urgent need for strategic reassessment. Risks include high financial leverage, as evidenced by the total debt-to-equity ratio of 1.28, and a negative interest coverage ratio, which could lead to liquidity issues. However, the stable promoter shareholding provides a glimmer of hope for potential restructuring efforts. If the company can successfully pivot its operational strategy and tap into emerging markets within the chemicals sector, it may regain investor confidence. Conversely, failure to address its financial inefficiencies could result in further losses and diminished market presence. Stakeholders should closely monitor quarterly results and any strategic initiatives aimed at revitalizing growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Alchemist Corporation Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,776 Cr. | 42.9 | 125/42.9 | 138 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 15.5 Cr. | 31.0 | 48.3/25.8 | 67.4 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 209 Cr. | 266 | 410/238 | 12.4 | 211 | 3.00 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,830 Cr. | 554 | 730/408 | 33.3 | 157 | 0.54 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 353 Cr. | 451 | 536/376 | 17.2 | 144 | 0.66 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,991.50 Cr | 580.54 | 175.63 | 160.00 | 0.49% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.03 | 0.03 | 0.03 | 0.09 | 0.04 | 0.04 | 0.04 | 0.12 | 0.05 | 0.09 | 0.05 | 1.14 | 0.05 |
| Operating Profit | -0.03 | -0.03 | -0.03 | -0.09 | -0.04 | -0.04 | -0.04 | -0.12 | -0.05 | -0.09 | -0.05 | -1.14 | -0.05 |
| OPM % | |||||||||||||
| Other Income | 0.02 | 0.03 | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 | 0.03 | 0.03 | 0.03 | 1.03 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.01 | 0.00 | -0.09 | -0.09 | -0.04 | -0.07 | -0.06 | 0.29 | -0.04 | -0.08 | -0.03 | -0.13 | -0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 17.24% | 0.00% | 0.00% | 0.00% | 0.00% | 60.00% | |
| Net Profit | -0.01 | 0.00 | -0.09 | -0.09 | -0.04 | -0.07 | -0.06 | 0.24 | -0.04 | -0.08 | -0.03 | -0.13 | -0.07 |
| EPS in Rs | -0.02 | 0.00 | -0.18 | -0.18 | -0.08 | -0.14 | -0.12 | 0.49 | -0.08 | -0.16 | -0.06 | -0.28 | -0.14 |
Last Updated: August 20, 2025, 12:10 am
Below is a detailed analysis of the quarterly data for Alchemist Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.14 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 1.09 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.05 Cr.. The value appears strong and on an upward trend. It has increased from -1.14 Cr. (Mar 2025) to -0.05 Cr., marking an increase of 1.09 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.03 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.03 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.05 Cr.. The value appears strong and on an upward trend. It has increased from -0.13 Cr. (Mar 2025) to -0.05 Cr., marking an increase of 0.08 Cr..
- For Tax %, as of Jun 2025, the value is 60.00%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Mar 2025) to 60.00%, marking an increase of 60.00%.
- For Net Profit, as of Jun 2025, the value is -0.07 Cr.. The value appears strong and on an upward trend. It has increased from -0.13 Cr. (Mar 2025) to -0.07 Cr., marking an increase of 0.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.14. The value appears strong and on an upward trend. It has increased from -0.28 (Mar 2025) to -0.14, marking an increase of 0.14.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:00 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.34 | 0.00 | 0.40 | 0.34 | 0.34 | 0.46 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.12 | 0.10 | 0.60 | 0.28 | 1.66 | 0.27 | 0.29 | 0.31 | 0.24 | 0.18 | 0.24 | 1.31 | 1.33 |
| Operating Profit | -0.12 | -0.10 | -0.26 | -0.28 | -1.26 | 0.07 | 0.05 | 0.15 | -0.19 | -0.18 | -0.24 | -1.31 | -1.33 |
| OPM % | -76.47% | -315.00% | 20.59% | 14.71% | 32.61% | -380.00% | |||||||
| Other Income | -0.07 | -0.02 | 0.03 | -0.38 | 1.30 | 0.01 | 0.00 | -2.04 | -1.42 | 0.00 | 0.43 | 1.11 | 1.09 |
| Interest | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.07 | 0.05 |
| Depreciation | 0.01 | 0.02 | 0.01 | 0.01 | 0.04 | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.21 | -0.15 | -0.25 | -0.67 | -0.01 | 0.05 | 0.02 | -1.92 | -1.62 | -0.18 | 0.12 | -0.27 | -0.29 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | 0.00% | 50.00% | 0.00% | 0.00% | 0.00% | 41.67% | 0.00% | |
| Net Profit | -0.21 | -0.14 | -0.25 | -0.67 | 0.00 | 0.04 | 0.02 | -1.91 | -1.62 | -0.18 | 0.07 | -0.27 | -0.31 |
| EPS in Rs | -0.43 | -0.28 | -0.51 | -1.36 | 0.00 | 0.08 | 0.04 | -3.89 | -3.30 | -0.37 | 0.14 | -0.57 | -0.64 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 33.33% | -78.57% | -168.00% | 100.00% | -50.00% | -9650.00% | 15.18% | 88.89% | 138.89% | -485.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | -111.90% | -89.43% | 268.00% | -150.00% | -9600.00% | 9665.18% | 73.71% | 50.00% | -624.60% |
Alchemist Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -19% |
| TTM: | -557% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 29% |
| 3 Years: | 35% |
| 1 Year: | 71% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -1% |
| 3 Years: | -1% |
| Last Year: | -3% |
Last Updated: September 5, 2025, 2:11 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4,573.24 | 2,162.62 | 2,544.26 | 2,254.41 | 0.00 | 0.00 | ||||||
| Inventory Days | 1,233.11 | 0.00 | ||||||||||
| Days Payable | 4,281.35 | |||||||||||
| Cash Conversion Cycle | 1,524.99 | 2,162.62 | 2,544.26 | 2,254.41 | 0.00 | 0.00 | ||||||
| Working Capital Days | 128.82 | 1,213.62 | 1,545.88 | 1,610.29 | -372.93 | -1,825.00 | ||||||
| ROCE % | -0.64% | -0.55% | -1.19% | -1.31% | 0.00% | 0.26% | 0.10% | 0.65% | -1.14% | -1.13% | 1.17% | -2.25% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.55 | 0.13 | -0.37 | -3.29 | -3.89 |
| Diluted EPS (Rs.) | -0.55 | 0.13 | -0.37 | -3.29 | -3.89 |
| Cash EPS (Rs.) | -0.54 | 0.13 | -0.36 | -3.27 | -3.84 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.13 | 2.39 | 1.56 | 1.93 | 4.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.13 | 32.28 | 31.45 | 31.82 | 35.11 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.11 | 0.93 |
| PBDIT / Share (Rs.) | -0.41 | 0.36 | -0.36 | 0.22 | 0.31 |
| PBIT / Share (Rs.) | -0.41 | 0.36 | -0.36 | 0.19 | 0.26 |
| PBT / Share (Rs.) | -0.54 | 0.23 | -0.36 | -3.29 | -3.90 |
| Net Profit / Share (Rs.) | -0.54 | 0.13 | -0.36 | -3.29 | -3.89 |
| NP After MI And SOA / Share (Rs.) | -0.56 | 0.13 | -0.36 | -3.29 | -3.89 |
| PBDIT Margin (%) | 0.00 | 0.00 | -12020.00 | 191.22 | 33.58 |
| PBIT Margin (%) | 0.00 | 0.00 | -12020.00 | 172.28 | 28.07 |
| PBT Margin (%) | 0.00 | 0.00 | -12073.33 | -2835.96 | -419.48 |
| Net Profit Margin (%) | 0.00 | 0.00 | -12073.33 | -2834.38 | -418.47 |
| NP After MI And SOA Margin (%) | 0.00 | 0.00 | -11973.33 | -2834.03 | -418.06 |
| Return on Networth / Equity (%) | -49.91 | 5.61 | -23.42 | -170.72 | -81.97 |
| Return on Capital Employeed (%) | -36.01 | 1.13 | -1.16 | 0.61 | 0.73 |
| Return On Assets (%) | -20.94 | 0.37 | -1.01 | -9.25 | -9.88 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.06 | 0.21 | 0.13 |
| Total Debt / Equity (X) | 1.28 | 0.50 | 0.06 | 0.21 | 0.13 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Current Ratio (X) | 1.72 | 0.73 | 0.71 | 0.84 | 0.74 |
| Quick Ratio (X) | 1.72 | 0.73 | 0.71 | 0.84 | 0.74 |
| Interest Coverage Ratio (X) | -3.08 | 2.75 | -225.38 | 30.28 | 56.89 |
| Interest Coverage Ratio (Post Tax) (X) | -3.08 | 1.98 | -225.38 | 27.53 | 49.26 |
| Enterprise Value (Cr.) | 6.36 | 8.40 | 8.44 | 8.17 | 2.87 |
| EV / Net Operating Revenue (X) | 0.00 | 0.00 | 5623.62 | 143.28 | 6.28 |
| EV / EBITDA (X) | -31.35 | 46.45 | -46.79 | 74.92 | 18.70 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.00 | 5618.68 | 139.67 | 5.64 |
| Price / BV (X) | 10.18 | 6.64 | 11.00 | 8.42 | 1.11 |
| Price / Net Operating Revenue (X) | 0.00 | 0.00 | 5716.67 | 140.87 | 5.65 |
| EarningsYield | -0.04 | 0.01 | -0.02 | -0.20 | -0.74 |
After reviewing the key financial ratios for Alchemist Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to -0.55, marking a decrease of 0.68.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to -0.55, marking a decrease of 0.68.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 3. It has decreased from 0.13 (Mar 24) to -0.54, marking a decrease of 0.67.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.13. It has decreased from 2.39 (Mar 24) to 1.13, marking a decrease of 1.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.13. It has decreased from 32.28 (Mar 24) to 1.13, marking a decrease of 31.15.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has decreased from 0.36 (Mar 24) to -0.41, marking a decrease of 0.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 0. It has decreased from 0.36 (Mar 24) to -0.41, marking a decrease of 0.77.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 0. It has decreased from 0.23 (Mar 24) to -0.54, marking a decrease of 0.77.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 2. It has decreased from 0.13 (Mar 24) to -0.54, marking a decrease of 0.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 2. It has decreased from 0.13 (Mar 24) to -0.56, marking a decrease of 0.69.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 8. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is -49.91. This value is below the healthy minimum of 15. It has decreased from 5.61 (Mar 24) to -49.91, marking a decrease of 55.52.
- For Return on Capital Employeed (%), as of Mar 25, the value is -36.01. This value is below the healthy minimum of 10. It has decreased from 1.13 (Mar 24) to -36.01, marking a decrease of 37.14.
- For Return On Assets (%), as of Mar 25, the value is -20.94. This value is below the healthy minimum of 5. It has decreased from 0.37 (Mar 24) to -20.94, marking a decrease of 21.31.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.28. This value exceeds the healthy maximum of 1. It has increased from 0.50 (Mar 24) to 1.28, marking an increase of 0.78.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Current Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 0.73 (Mar 24) to 1.72, marking an increase of 0.99.
- For Quick Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 0.73 (Mar 24) to 1.72, marking an increase of 0.99.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 3. It has decreased from 2.75 (Mar 24) to -3.08, marking a decrease of 5.83.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 3. It has decreased from 1.98 (Mar 24) to -3.08, marking a decrease of 5.06.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6.36. It has decreased from 8.40 (Mar 24) to 6.36, marking a decrease of 2.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EV / EBITDA (X), as of Mar 25, the value is -31.35. This value is below the healthy minimum of 5. It has decreased from 46.45 (Mar 24) to -31.35, marking a decrease of 77.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 10.18. This value exceeds the healthy maximum of 3. It has increased from 6.64 (Mar 24) to 10.18, marking an increase of 3.54.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EarningsYield, as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.04, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alchemist Corporation Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -36.01% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -49.91% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -3.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 175.63)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.28
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | R-4, Unit No. 103, First Floor, New Delhi Delhi 110017 | info@alchemist-corp.com http://www.alchemist-corp.com |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Pooja Rastogi | Managing Director |
| Mrs. Meena Rastogi | Non Executive Director |
| Mrs. Sheetal Jain | Non Executive Director |
| Mr. Kailash | Independent Director |
| Mr. Sanjeev Kumar | Independent Director |